Home
OCEA
OCEA News

Latest Ocean Biomedical Inc. (OCEA) News on February 23, 2025

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

GlobeNewswire

13 days ago

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

MT Newswires

25 days ago

Ocean Biomedical Receives Additional NIH Funding for Malaria Vaccine Research; Shares Up Pre-Bell

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

GlobeNewswire

25 days ago

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

GlobeNewswire

3 months ago

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

GlobeNewswire

4 months ago

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

GlobeNewswire

5 months ago

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

GlobeNewswire

6 months ago

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

GlobeNewswire

6 months ago

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

GlobeNewswire

9 months ago

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

MT Newswires

9 months ago

Ocean Biomedical Gets Nasdaq Noncompliance Notice; Shares Down

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

GlobeNewswire

9 months ago

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

GlobeNewswire

9 months ago

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

GlobeNewswire

10 months ago

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

13 Hot Stocks to Invest in According to Wall Street Analysts

Insider Monkey

a year ago

13 Hot Stocks to Invest in According to Wall Street Analysts

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL

GlobeNewswire

a year ago

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL

Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting

GlobeNewswire

a year ago

Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting

GlobeNewswire

a year ago

Digihost Announces 65% Year-Over-Year Increase in Bitcoin Mined and Provides January 2024 Production Update

Golden Matrix Group, Inc.'s (NASDAQ:GMGI) 40% gain last week benefited both individual investors who own 45% as well as insiders

Simply Wall St.

a year ago

Golden Matrix Group, Inc.'s (NASDAQ:GMGI) 40% gain last week benefited both individual investors who own 45% as well as insiders

Akoustis Announces Proposed Public Offering of Common Stock

GlobeNewswire

a year ago

Akoustis Announces Proposed Public Offering of Common Stock

Precision Optics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

PR Newswire

a year ago

Precision Optics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

GlobeNewswire

a year ago

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

We're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Rate

GlobeNewswire

a year ago

Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination

DHI Group, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Business Wire

a year ago

DHI Group, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

American Resources' (AREC) Arm Executes MOU With Duesenfeld

Zacks

a year ago

American Resources' (AREC) Arm Executes MOU With Duesenfeld

Expion360 Announces Next Generation GC2 and Group 27 Series LiFePO4 Batteries for Recreational Vehicles

GlobeNewswire

a year ago

Expion360 Announces Next Generation GC2 and Group 27 Series LiFePO4 Batteries for Recreational Vehicles

After Plunging -41.57% in 4 Weeks, Here's Why the Trend Might Reverse for Edgio (EGIO)

Zacks

a year ago

After Plunging -41.57% in 4 Weeks, Here's Why the Trend Might Reverse for Edgio (EGIO)

With 29% ownership in Elevation Oncology, Inc. (NASDAQ:ELEV), hedge funds investors have a lot riding on the business

Simply Wall St.

a year ago

With 29% ownership in Elevation Oncology, Inc. (NASDAQ:ELEV), hedge funds investors have a lot riding on the business

eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024

GlobeNewswire

a year ago

eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024

5 Solid Stocks to Buy on a Solid Jump in Factory Orders

Zacks

a year ago

5 Solid Stocks to Buy on a Solid Jump in Factory Orders

Mural Oncology Announces Enhancements to Late-Stage Clinical Trials

GlobeNewswire

a year ago

Mural Oncology Announces Enhancements to Late-Stage Clinical Trials

Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024

Business Wire

a year ago

Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024

GlobeNewswire

a year ago

Digihost’s Hashrate Doubles to 2EH/s as of January 1st 2024

TSX Venture Exchange Stock Maintenance Bulletins

CNW Group

a year ago

TSX Venture Exchange Stock Maintenance Bulletins

Surf Air Mobility Announces Oliver Reeves as Chief Financial Officer

Business Wire

a year ago

Surf Air Mobility Announces Oliver Reeves as Chief Financial Officer

Big Lots, Inc. (NYSE:BIG) is favoured by institutional owners who hold 73% of the company

Simply Wall St.

a year ago

Big Lots, Inc. (NYSE:BIG) is favoured by institutional owners who hold 73% of the company

Reuters

a year ago

AlloVir scraps late-stage studies testing antiviral cell therapy

AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy

GlobeNewswire

a year ago

AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy

First Community Corporation Announces 2024 Earnings Release Schedule

PR Newswire

a year ago

First Community Corporation Announces 2024 Earnings Release Schedule

/DISREGARD RELEASE: YS Biopharma/

PR Newswire

a year ago

/DISREGARD RELEASE: YS Biopharma/

Business Wire

a year ago

The Mexico Equity and Income Fund, Inc. Announces Cash Dividend

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

InvestorPlace

a year ago

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

Quantum-Si Expands Global Reach with Addition of New Distributor

Business Wire

a year ago

Quantum-Si Expands Global Reach with Addition of New Distributor

Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors

Business Wire

a year ago

Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors

Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer

GlobeNewswire

a year ago

Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

GlobeNewswire

a year ago

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody

Benzinga

a year ago

EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody

Alliance Entertainment Announces Partnership with High-end Collectible Sales Channel Grail Game

GlobeNewswire

a year ago

Alliance Entertainment Announces Partnership with High-end Collectible Sales Channel Grail Game

Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody

GlobeNewswire

a year ago

Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

GlobeNewswire

a year ago

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Castor Maritime Inc. Announces the Sale of the M/V Magic Moon for $11.8 Million and the Completion of the Sale of the M/V Magic Phoenix

GlobeNewswire

a year ago

Castor Maritime Inc. Announces the Sale of the M/V Magic Moon for $11.8 Million and the Completion of the Sale of the M/V Magic Phoenix

12 Best Debt Free Stocks To Buy

Insider Monkey

a year ago

12 Best Debt Free Stocks To Buy

Zacks Small Cap Research

a year ago

CRVO: Publications Highlight Neflamapimod as Potential Disease-Modifying Therapy for Major Dementias…

Ondas Holdings Inc. (NASDAQ:ONDS) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Ondas Holdings Inc. (NASDAQ:ONDS) Q3 2023 Earnings Call Transcript

Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics

GlobeNewswire

a year ago

Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics

GuruFocus.com

a year ago

Beneficient (BENF) Reports Mixed Second Quarter Fiscal 2024 Results

Beneficient Reports Results for Second Quarter Fiscal 2024

GlobeNewswire

a year ago

Beneficient Reports Results for Second Quarter Fiscal 2024

CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights

PR Newswire

a year ago

CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Business Wire

a year ago

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Forian Inc. Announces Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Forian Inc. Announces Third Quarter 2023 Financial Results

BGSF, Inc. Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

BGSF, Inc. Reports Third Quarter 2023 Financial Results

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcript

Inuvo Enhances its AI-Generated IntentKey Insights Dashboard for Clients

GlobeNewswire

a year ago

Inuvo Enhances its AI-Generated IntentKey Insights Dashboard for Clients

Brightcove and Socialive Partner to Enhance Livestream Management Offerings for Internal Communications

Business Wire

a year ago

Brightcove and Socialive Partner to Enhance Livestream Management Offerings for Internal Communications

Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule, and Updates on Several Preclinical Candidates for the Treatment of Chronic Hepatitis B, in Addition to the Recently Announced Late Breaker Poster (#5028-C)

GlobeNewswire

a year ago

Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule, and Updates on Several Preclinical Candidates for the Treatment of Chronic Hepatitis B, in Addition to the Recently Announced Late Breaker Poster (#5028-C)

ACRES COMMERCIAL REALTY CORP. ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER DAVID J. BRYANT AND NAMES ELDRON C. BLACKWELL AS SUCCESSOR

PR Newswire

a year ago

ACRES COMMERCIAL REALTY CORP. ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER DAVID J. BRYANT AND NAMES ELDRON C. BLACKWELL AS SUCCESSOR

Share on Social Networks: